1Y Target$30.99Near-term target
5Y Target$43.40Compound horizon
10Y Target$63.80Long-dated conviction
FCF—TTM—FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev-25.8%TTM YoYFRevenue -25.8% — severe decline
D/E0.71BD/E 0.71 — at market average, manageable
P/E23.0xBP/E 23.0 — moderate premium, defensible with growth
PEG—proxy—PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $22.2b. Trading near 52-week high of $27.70 — momentum setup, limited technical margin of safety. Revenue -26% — in contraction; any catalyst that reverses this triggers re-rating.
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the 7-grade screen.
Risk
Revenue contracting -26% — the operational turn is not yet visible in the top line. Trading within 3% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
Horizon
1-3 yr $30.99 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $43.40 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $63.80 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.